Despite studies that show UV-C is effective and safe, some individuals still refuse to believe it, based on experience with or studies based on first generation UV-C technology.
For decades, ultraviolet C light (UV-C) has been used to reduce health care-associated infections in health care facilities. It also has been proven to be effective against SARS-CoV-2, but not everyone believes that that UV-C is worth the limited funds of health care facilities. Specifically, the health care sector wanted to know information about the UV-C technology, so a leader in impartial health care research, KLAS Research, conducted a study of Surfacide, a UV-C technology company, to do a deep dive into the industry.
UV Light Sterilization, an Infection Control Today® special series
(Adobe Stock)
The newly released report from KLAS Research, about Surfacide UV-C Technology covers how Surfacide is seen within the health care industry. In this first of 2 segments of an exclusive interview, Gunner Lyslo, founder and CEO of Surfacide speaks with Infection Control Today® (ICT®) about what the report means for both Surfacide and the industry itself, how the industry has evolved and where it is going, and what specifics individuals and companies looking into UV-C technology should look for to verify the product is both legitimate and safe for the workers and visitors to their facilities because not all UV-C technology is created equal.
“If you're using the technology, and you have appropriate indications for use, it provides significant value significant value to the patients, to the frontline health workers, to all of those other elements,” Lyslo told ICT®. “For those who either were using first generation [UVC] technology, and…they had such a bad taste in their mouth, they've just thrown in the towel, or now you have non-health care. Individuals who are considering this [technology], we don't want them to have a bad taste. It's the proverbial poisoning of the well. That's one of the things that Surfacide is doing. We're elevating ourselves; we're shooting everybody straight. This is exactly how the technology works. These are its strengths. These are its limitations. You can then make an evidence-based decision to determine does this work for your organization.”
The UVC industry has its doubters, and Lyslo addresses those “naysayers.” He examines how he responds to the cynics who claim UV light disinfection is a waste of money, time, and resources. He also talks about what questions an individual who is considering a UVC product should ask to make sure they are getting a quality product—Surfacide's or another.
This is part of an ICT® on-going special reporting on UV-C technology.
APIC Salutes 2025 Trailblazers in Infection Prevention and Control
June 18th 2025From a lifelong mentor to a rising star, the Association for Professionals in Infection Control and Epidemiology (APIC) honored leaders across the career spectrum at its 2025 Annual Conference in Phoenix, recognizing individuals who enhance patient safety through research, leadership, and daily practice.
Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story
June 17th 2025Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.
Swift Isolation Protocol Shields Chicago Children’s Hospital During 2024 Measles Surge
June 17th 2025When Chicago logged its first measles cases linked to crowded migrant shelters last spring, one pediatric hospital moved in hours—not days—to prevent the virus from crossing its threshold. Their playbook offers a ready template for the next communicable-disease crisis.
Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline
June 16th 2025A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.